DR. DARREN MICHAEL KOCS MD NPI 1972541357

NPI Information

  • NPI: 1972541357
  • Provider Name: DR. DARREN MICHAEL KOCS, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2410 ROUND ROCK AVE
    SUITE 150
    ROUND ROCK, TX
    ZIP 78681
  • Phone: (512) 341-8724

Map and Directions

Get Directions

NPI Details

DR. Darren Michael Kocs, MD is a hematology and oncology internal medicine in Round Rock, TX with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Darren Michael Kocs, MD NPI is 1972541357. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Graduation Year:1997

The provider's business location address is:

2410 ROUND ROCK AVE
SUITE 150
ROUND ROCK, TX
ZIP 78681-003
Phone: (512) 341-8724
Fax: (512) 341-9440

The NPI 1972541357 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Magnesium level (HCPCS:83735)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Immunologic analysis technique on serum (HCPCS:86320)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Unclassified drugs (HCPCS:J3490)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Uric acid level, blood (HCPCS:84550)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Automated urinalysis test (HCPCS:81003)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Red blood count, automated test (HCPCS:85045)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Declotting of central venous tube (HCPCS:36593)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)

The enumeration date for this NPI number is 6/4/2006 and was last updated on 2/21/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyL6477TEXASNo
2207RH0003XInternal MedicineHematology & OncologyL6477TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
18R1488OTHERTEXASBLUE CROSS OF TX
2P00033648MEDICARE PINTEXAS
38A8159MEDICARE PINTEXAS
4H86813MEDICARE UPIN
58D5778MEDICARE PINTEXAS
68D5773MEDICARE PINTEXAS
78A8160MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.